All news

Positive opinion on Provenge

Added: Monday 22 July 2013

The Committe for Medicinal Products for Human Use (CHMP) has given a positive opinion on Provenge, for the treatment of metastatic prostate cancer. This and other news was reported in <cite>Human Medicines Highlights</cite>, the newsletter from the European Medicines Agency.


+  http://www.ema.europa.eu/docs/en_GB/document_library/Newsletter/2013/07/WC500145479.pdf


//